RAFAEL HOLDINGS, INC. Earnings Per Share (Basic)
RAFAEL HOLDINGS, INC. (RFL) reported Earnings Per Share (Basic) of -$0.08 per share for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-04-30 was -$0.08.
- RAFAEL HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-01-31 was -$0.13.
- RAFAEL HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-10-31 was -$0.19.
- RAFAEL HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-04-30 was -$0.19.
- RAFAEL HOLDINGS, INC. earnings per share, basic for fiscal 2025 was -$1.04.
- RAFAEL HOLDINGS, INC. earnings per share, basic for fiscal 2024 was -$1.45.
- RAFAEL HOLDINGS, INC. earnings per share, basic for fiscal 2023 was -$0.08.
- RAFAEL HOLDINGS, INC. earnings per share, basic for fiscal 2022 was -$6.31.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | -$0.08 10-Q · filed 2026-06-11 | -$0.40 10-Q · filed 2026-06-11 | |||
| 2026-01-31 | -$0.13 10-Q · filed 2026-03-16 | -$0.32 10-Q · filed 2026-03-16 | |||
| 2025-10-31 | -$0.19 10-Q · filed 2025-12-12 | ||||
| 2025-07-31 | -$1.04 10-K · filed 2025-10-29 | ||||
| 2025-04-30 | -$0.19 10-Q · filed 2026-06-11 | -$0.73 10-Q · filed 2026-06-11 | |||
| 2025-01-31 | -$0.19 10-Q · filed 2026-03-16 | -$0.57 10-Q · filed 2026-03-16 | |||
| 2024-10-31 | -$0.37 10-Q · filed 2025-12-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$1.92 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-12-12 | |
| 2024-07-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-10-29 | -$1.54 derived: net income ÷ weighted average shares · filed 2025-10-29 | -$1.29 derived: net income ÷ weighted average shares · filed 2025-10-29 | -$1.45 10-K · filed 2025-10-29 | |
| 2024-04-30 | -$1.36 10-Q · filed 2025-06-11 | -$1.11 derived: net income ÷ weighted average shares · filed 2025-06-11 | -$1.26 10-Q · filed 2025-06-11 | -$1.21 derived: net income ÷ weighted average shares · filed 2025-06-11 | |
| 2024-01-31 | $0.26 10-Q · filed 2025-03-14 | $0.10 10-Q · filed 2025-03-14 | $0.15 derived: net income ÷ weighted average shares · filed 2025-03-14 | $0.09 derived: net income ÷ weighted average shares · filed 2025-03-14 | |
| 2023-10-31 | -$0.15 10-Q · filed 2024-12-11 | -$0.10 derived: net income ÷ weighted average shares · filed 2024-12-20 | -$0.16 derived: net income ÷ weighted average shares · filed 2024-12-20 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-12-20 | |
| 2023-07-31 | $0.05 derived: net income ÷ weighted average shares · filed 2024-12-20 | -$0.01 derived: net income ÷ weighted average shares · filed 2024-12-20 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-12-20 | -$0.08 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | -$0.06 10-Q · filed 2024-06-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-06-14 | -$0.14 10-Q · filed 2024-06-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-06-14 | |
| 2023-01-31 | -$0.14 10-Q · filed 2024-03-14 | -$0.08 10-Q · filed 2024-03-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-03-14 | |
| 2022-10-31 | $0.07 10-Q · filed 2023-12-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-12-14 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-12-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-12-14 | |
| 2022-07-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-10-30 | -$0.51 derived: net income ÷ weighted average shares · filed 2023-10-30 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-10-30 | -$6.31 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$0.28 10-Q · filed 2023-06-13 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-06-13 | -$6.16 10-Q · filed 2023-06-13 | -$6.97 derived: net income ÷ weighted average shares · filed 2023-06-13 | |
| 2022-01-31 | -$0.12 10-Q · filed 2023-03-14 | -$5.91 10-Q · filed 2023-03-14 | -$6.78 derived: net income ÷ weighted average shares · filed 2023-03-14 | -$7.11 derived: net income ÷ weighted average shares · filed 2023-03-14 | |
| 2021-10-31 | -$5.91 derived: net income ÷ weighted average shares · filed 2022-12-13 | -$6.84 derived: net income ÷ weighted average shares · filed 2022-12-13 | -$7.18 derived: net income ÷ weighted average shares · filed 2022-12-13 | ||
| 2021-07-31 | -$0.71 derived: net income ÷ weighted average shares · filed 2022-10-31 | -$0.88 derived: net income ÷ weighted average shares · filed 2022-10-31 | -$1.49 10-K · filed 2022-10-31 | ||
| 2021-04-30 | -$0.15 10-Q · filed 2022-06-14 | -$0.75 10-Q · filed 2022-06-14 | |||
| 2018-10-31 | -$0.75 10-K · filed 2018-10-15 | ||||
| 2018-07-31 | -$0.05 10-K · filed 2018-10-15 | -$0.93 10-K · filed 2018-10-15 | |||
| 2018-04-30 | -$0.06 10-K · filed 2018-10-15 | -$0.04 10-Q · filed 2018-06-11 | -$0.83 10-Q · filed 2018-06-11 | ||
| 2018-01-31 | -$0.07 10-K · filed 2018-10-15 | ||||
| 2017-10-31 | $0.01 10-K · filed 2018-10-15 | ||||
| 2017-07-31 | -$0.01 10-K · filed 2018-10-15 | $0.01 10-K · filed 2018-10-15 | |||
| 2017-04-30 | -$0.01 10-K · filed 2018-10-15 | $0.02 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | $0.01 10-K · filed 2018-10-15 | ||||
| 2016-07-31 | $0.06 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |